Connor, Clark & Lunn Investment Management (CC&L)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.64M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $428K | Buy |
|
|||||
|
2024
Q2 | $247K | Sell |
|
|||||
|
2024
Q1 | $9.9M | Sell |
|
|||||
|
2023
Q4 | $13.8M | Sell |
|
|||||
|
2023
Q3 | $67.7M | Buy |
|
|||||
|
2023
Q2 | $65M | Buy |
|
|||||
|
2023
Q1 | $68.9M | Buy |
|
|||||
|
2022
Q4 | $66.5M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5.98M | Sell |
|
|||||
|
2022
Q1 | $7.42M | Sell |
|
|||||
|
2021
Q4 | $41.1M | Sell |
|
|||||
|
2021
Q3 | $99.7M | Buy |
|
|||||
|
2021
Q2 | $65.1M | Buy |
|
|||||
|
2021
Q1 | $41.4M | Buy |
|
|||||
|
2020
Q4 | $19.3M | Sell |
|
|||||
|
2020
Q3 | $38.9M | Buy |
|
|||||
|
2020
Q2 | $8.19M | Sell |
|
|||||
|
2020
Q1 | $22.6M | Buy |
|
|||||
|
2019
Q4 | $23.5M | Sell |
|
|||||
|
2019
Q3 | $66.2M | Buy |
|
|||||
|
2019
Q2 | $16.5M | Sell |
|
|||||
|
2019
Q1 | $29.6M | Buy |
|
|||||
|
2018
Q4 | $27.3M | Buy |
|
|||||
|
2018
Q3 | $24.6M | Sell |
|
|||||
|
2018
Q2 | $37.3M | Sell |
|
|||||
|
2018
Q1 | $46.7M | Buy |
|
|||||
|
2017
Q4 | $37.9M | Sell |
|
|||||
|
2017
Q3 | $41.8M | Buy |
|
|||||
|
2017
Q2 | $27.4M | Sell |
|
|||||
|
2017
Q1 | $30.5M | Sell |
|
|||||
|
2016
Q4 | $35.2M | Sell |
|
|||||
|
2016
Q3 | $46.2M | Buy |
|
|||||
|
2016
Q2 | $43.8M | Sell |
|
|||||
|
2016
Q1 | $48.5M | Buy |
|
|||||
|
2015
Q4 | $47.8M | Sell |
|
|||||
|
2015
Q3 | $48.2M | Buy |
|
|||||
|
2015
Q2 | $16.9M | Buy |
|
|||||
|
2015
Q1 | $8.8M | Buy |
|
|||||
|
2014
Q4 | $7.73M | Sell |
|
|||||
|
2014
Q3 | $29.9M | Sell |
|
|||||
|
2014
Q2 | $49.6M | Buy |
|
|||||
|
2014
Q1 | $29.5M | Sell |
|
|||||
|
2013
Q4 | $29.9M | Buy |
|
|||||
|
2013
Q3 | $11.6M | Buy |
|
|||||
|
2013
Q2 | $11.1M | Buy |
|